Evicenter
MarkdownMedical informationP&T meetings
Barzolvolimab (CDX-0159)

Chronic spontaneous urticaria

Launch
Not announced
Last updated
177 sources

Product information and disease descriptionPlace of product in therapyDisease description

Natural history, survival, and mortality

13 evidence topics · 9 sources

Remission rates at years 1, 5, and 20: targeted literature review